Pathogenesis of inflammatory demyelination: implications for therapy.
Hartung
H P
HP
D001324:Autoantigens / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000502:physiology; D002490:Central Nervous System / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology*; D009185:Myelin Proteins / Q000276:immunology; D010525:Peripheral Nerves / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000188:drug therapy / Q000276:immunology*; D016201:Receptors, Lymphocyte Homing / Q000276:immunology
D001324:Autoantigens; D015815:Cell Adhesion Molecules; D016207:Cytokines; D018836:Inflammation Mediators; D009185:Myelin Proteins; D016201:Receptors, Lymphocyte Homing